These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 28405517)

  • 1. Hematopoietic stem cell-derived myeloid and plasmacytoid DC-based vaccines are highly potent inducers of tumor-reactive T cell and NK cell responses
    Thordardottir S; Schaap N; Louer E; Kester MG; Falkenburg JH; Jansen J; Radstake TR; Hobo W; Dolstra H
    Oncoimmunology; 2017; 6(3):e1285991. PubMed ID: 28405517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human CD34
    van Eck van der Sluijs J; van Ens D; Brummelman J; Heister D; Sareen A; Truijen L; van Ingen Schenau DS; Heemskerk MHM; Griffioen M; Kester MGD; Schaap NPM; Jansen JH; van der Waart AB; Dolstra H; Hobo W
    Cell Mol Life Sci; 2023 Sep; 80(10):298. PubMed ID: 37728691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinically applicable CD34
    van Eck van der Sluijs J; van Ens D; Thordardottir S; Vodegel D; Hermens I; van der Waart AB; Falkenburg JHF; Kester MGD; de Rink I; Heemskerk MHM; Borst J; Schaap NPM; Jansen JH; Xiao Y; Dolstra H; Hobo W
    Cancer Immunol Immunother; 2021 Nov; 70(11):3167-3181. PubMed ID: 33796917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The aryl hydrocarbon receptor antagonist StemRegenin 1 promotes human plasmacytoid and myeloid dendritic cell development from CD34+ hematopoietic progenitor cells.
    Thordardottir S; Hangalapura BN; Hutten T; Cossu M; Spanholtz J; Schaap N; Radstake TR; van der Voort R; Dolstra H
    Stem Cells Dev; 2014 May; 23(9):955-67. PubMed ID: 24325394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. siRNA silencing of PD-1 ligands on dendritic cell vaccines boosts the expansion of minor histocompatibility antigen-specific CD8(+) T cells in NOD/SCID/IL2Rg(null) mice.
    van der Waart AB; Fredrix H; van der Voort R; Schaap N; Hobo W; Dolstra H
    Cancer Immunol Immunother; 2015 May; 64(5):645-54. PubMed ID: 25724840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CLEC12A-Mediated Antigen Uptake and Cross-Presentation by Human Dendritic Cell Subsets Efficiently Boost Tumor-Reactive T Cell Responses.
    Hutten TJ; Thordardottir S; Fredrix H; Janssen L; Woestenenk R; Tel J; Joosten B; Cambi A; Heemskerk MH; Franssen GM; Boerman OC; Bakker LB; Jansen JH; Schaap N; Dolstra H; Hobo W
    J Immunol; 2016 Oct; 197(7):2715-25. PubMed ID: 27566820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmacytoid Dendritic Cells as Cell-Based Therapeutics: A Novel Immunotherapy to Treat Human Immunodeficiency Virus Infection?
    van der Sluis RM; Egedal JH; Jakobsen MR
    Front Cell Infect Microbiol; 2020; 10():249. PubMed ID: 32528903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo generation of interstitial and Langerhans cell-like dendritic cell subset-based vaccines for hematological malignancies.
    Hutten T; Thordardottir S; Hobo W; Hübel J; van der Waart AB; Cany J; Dolstra H; Hangalapura BN
    J Immunother; 2014 Jun; 37(5):267-77. PubMed ID: 24810638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naturally produced type I IFNs enhance human myeloid dendritic cell maturation and IL-12p70 production and mediate elevated effector functions in innate and adaptive immune cells.
    Sköld AE; Mathan TSM; van Beek JJP; Flórez-Grau G; van den Beukel MD; Sittig SP; Wimmers F; Bakdash G; Schreibelt G; de Vries IJM
    Cancer Immunol Immunother; 2018 Sep; 67(9):1425-1436. PubMed ID: 30019146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human blood myeloid and plasmacytoid dendritic cells cross activate each other and synergize in inducing NK cell cytotoxicity.
    van Beek JJ; Gorris MA; Sköld AE; Hatipoglu I; Van Acker HH; Smits EL; de Vries IJ; Bakdash G
    Oncoimmunology; 2016; 5(10):e1227902. PubMed ID: 27853652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fully closed and automated enrichment of primary blood dendritic cells for cancer immunotherapy.
    Schreibelt G; Duiveman-de Boer T; Pots JM; van Oorschot TGM; de Boer AJ; Scharenborg NM; van de Rakt MWMM; Bos K; de Goede AL; Petry K; Brüning M; Angerer C; Schöggl C; Dzionek A; de Vries IJM
    Methods Cell Biol; 2024; 183():33-50. PubMed ID: 38548417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ascorbic acid supports ex vivo generation of plasmacytoid dendritic cells from circulating hematopoietic stem cells.
    Laustsen A; van der Sluis RM; Gris-Oliver A; Hernández SS; Cemalovic E; Tang HQ; Pedersen LH; Uldbjerg N; Jakobsen MR; Bak RO
    Elife; 2021 Sep; 10():. PubMed ID: 34473049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysfunctional DC subsets in RCC patients: ex vivo correction to yield an effective anti-cancer vaccine.
    Gigante M; Blasi A; Loverre A; Mancini V; Battaglia M; Selvaggi FP; Maiorano E; Napoli A; Castellano G; Storkus WJ; Gesualdo L; Ranieri E
    Mol Immunol; 2009 Feb; 46(5):893-901. PubMed ID: 19041139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protamine-stabilized RNA as an ex vivo stimulant of primary human dendritic cell subsets.
    Sköld AE; van Beek JJ; Sittig SP; Bakdash G; Tel J; Schreibelt G; de Vries IJ
    Cancer Immunol Immunother; 2015 Nov; 64(11):1461-73. PubMed ID: 26275446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low Counts of Plasmacytoid Dendritic Cells after Engraftment Are Associated with High Early Mortality after Allogeneic Stem Cell Transplantation.
    Gonçalves MV; Yamamoto M; Kimura EY; Colturato VA; de Souza MP; Mauad M; Ikoma MV; Novis Y; Rocha V; Ginani VC; Wanderley de Oliveira Felix OM; Seber A; Kerbauy FR; Hamerschlak N; Orfao A; Rodrigues CA
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1223-9. PubMed ID: 25792371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient activation of LRH-1-specific CD8+ T-cell responses from transplanted leukemia patients by stimulation with P2X5 mRNA-electroporated dendritic cells.
    Overes IM; Fredrix H; Kester MG; Falkenburg JH; van der Voort R; de Witte TM; Dolstra H
    J Immunother; 2009; 32(6):539-51. PubMed ID: 19483655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DC-Based Vaccines for Cancer Immunotherapy.
    Fu C; Zhou L; Mi QS; Jiang A
    Vaccines (Basel); 2020 Nov; 8(4):. PubMed ID: 33255895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis.
    Jongbloed SL; Lebre MC; Fraser AR; Gracie JA; Sturrock RD; Tak PP; McInnes IB
    Arthritis Res Ther; 2006; 8(1):R15. PubMed ID: 16507115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monocyte-Derived Dendritic Cells with Silenced PD-1 Ligands and Transpresenting Interleukin-15 Stimulate Strong Tumor-Reactive T-cell Expansion.
    Van den Bergh JMJ; Smits ELJM; Berneman ZN; Hutten TJA; De Reu H; Van Tendeloo VFI; Dolstra H; Lion E; Hobo W
    Cancer Immunol Res; 2017 Aug; 5(8):710-715. PubMed ID: 28637876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Investigation of plasmacytoid dendritic cell reconstitution and its relationship with cGVHD and relapse after haploidentical hematopoietic stem cell transplantation].
    Wu JY; Huang XJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):342-7. PubMed ID: 17493344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.